KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
SEC fundamentals · as filed in 10-Q FY2026, period ended Jul 31, 2026 · updated Oct 22, 2026
as filed in 10-Q FY2026, period ended Jul 31, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Jul 31, 2026, KESTRA MEDICAL TECHNOLOGIES, LTD. reported revenue of $31.0M, net income of -$44.1M, and total assets of $347.4M. Every figure below is taken directly from KESTRA MEDICAL TECHNOLOGIES, LTD.'s SEC filings: each links to the source document on EDGAR.
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2026 | $95.1M | -$131.6M |
| FY2025 | $59.8M | -$113.8M |
| FY2024 | $27.8M | -$94.1M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Sep 14, 2026 | on EDGAR ↗ |
| 10-Q | Sep 14, 2026 | on EDGAR ↗ |
| 8-K | Sep 10, 2026 | on EDGAR ↗ |
| DEF 14A | Jul 28, 2026 | on EDGAR ↗ |
| 8-K | Jul 14, 2026 | on EDGAR ↗ |
| 10-K | Jul 14, 2026 | on EDGAR ↗ |
| 8-K | Mar 17, 2026 | on EDGAR ↗ |
| 10-Q | Mar 17, 2026 | on EDGAR ↗ |
| 10-Q | Dec 11, 2025 | on EDGAR ↗ |
| 8-K | Dec 11, 2025 | on EDGAR ↗ |
Balance Sheet
as of Jul 31, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Jul 31, 2026
| Revenue | $31.0M | Revenue | source ↗ |
| Net Income | -$44.1M | Net | source ↗ |
| Operating Income | -$37.7M | Operating | source ↗ |
| Gross Profit | $17.5M | Gross | source ↗ |
| Cost of Revenue | $13.5M | Cost | source ↗ |
| R&D Expense | $6.8M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Jul 31, 2026
| EPS (diluted) | $-0.75 | Earnings | source ↗ |
| EPS (basic) | $-0.75 | Earnings | source ↗ |
| Shares Outstanding | 59.6M | Entity | source ↗ |
| Cash from Operations | -$32.3M | Net | source ↗ |
| Cash from Financing | $22.5M | Net | source ↗ |
| Cash from Investing | -$21.4M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 41
- Net shares
- -406.9K
Restatement history
Point-in-timeNo material restatements detected across 88 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.
Deeper fundamentals
A free API key reaches KMTS’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KMTS
MCP tool:
get_sec_fundamentals ticker=KMTS - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KMTS/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=KMTS as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/KMTS/history
MCP tool:
get_fundamentals_history ticker=KMTS - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/KMTS
MCP tool:
get_financial_health ticker=KMTS
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.